Cara Therapeutics To Explore Strategic Alternatives
Written by Emily J. Thompson, Senior Investment Analyst
Updated: Jul 11 2024
0mins
Source: Business Insider
- Cara Therapeutics Strategic Options: The board of Cara Therapeutics has approved exploring strategic options to enhance operational efficiency by controlling costs and preserving cash.
- Exploration Details: There is no guarantee that this exploration will result in agreements or transactions, and the timeline for potential deals remains uncertain.
- Updates Policy: Cara Therapeutics stated that updates on the strategic exploration will only be provided if approved by the Board or if required by law.
- Financial Advisor: The company has engaged Piper Sandler & Co. as its financial advisor for this strategic process.
- Market Activity: In pre-market trading on the Nasdaq, Cara Therapeutics shares are up 9.06% at $0.31.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
